logo
Products
Services
Resources
Selection Guides
About
PE/Texas Red® Anti-human CD27 Antibody
LT27
LT27 is an anti-human monoclonal antibody that recognizes the CD27 antigen. CD27 (sometimes referred to as T14, S152 or TNFRSF7) is a 50 - 55 kD member of the TNF-R superfamily that is expressed on the surface of cells such as NK cells, B cells and T cells. In some organisms, CD27 is a promoter of T cell differentiation, acts to positively regulate NIK/NF-kappaB signaling and is involved in the negative regulation of apoptotic process. Furthermore, it plays a role in key cellular pathways, in particular, the tumor necrosis factor-mediated signaling pathway, cell surface receptor signaling pathway and extrinsic apoptotic signaling pathway. From a research standpoint, it is of biological interest due to its association with key macromolecules/ligands like TRAF5, TRAF2 and CD70. CD27 is a moderately popular antibody target, with over 11000 publications in the last decade. CD27 is essential for immunology and costimulatory molecules research, typically serving as a phenotypic marker for differentiating cell types in flow cytometric applications. This antibody was purified through affinity chromatography and conjugated to PE/Texas Red® (ex/em = 567/615 nm). It is compatible with the 561 nm laser and 615/20 nm bandpass filter (for example, as in the Agilent Technologies NovoCyte Advanteon).
product image
CatalogSize
Price
Quantity
102701U025 tests
Price
102701U1100 tests
Price
102701U2500 tests
Price
 
Antibody properties

Other namesT14, S152, TNFRSF7
CloneLT27
HostMouse
IsotypeIgG2a
ReactivityHuman
Spectral properties

Extinction coefficient (cm -1 M -1)
1960000
Excitation (nm)565
Emission (nm)613
Usage and storage

Intended useResearch Use Only (RUO)
Contact us

Telephone
Fax
Emailsales@aatbio.com
InternationalSee distributors
Bulk requestInquire
Custom sizeInquire
Technical SupportContact us
Request quotationRequest
Purchase orderSend to sales@aatbio.com
ShippingStandard overnight for United States, inquire for international
Page updated on August 21, 2026